{
  "url": "https://techhq.dc.lilly.com/docs/solution/ai/examples/enterprise/PRD",
  "title": "Press Release Drafter (PRD) | Tech HQ",
  "description": "Last Updated: July 25, 2025",
  "h1": [
    "Press Release Drafter (PRD)",
    "An Agentic AI System for Press Release Generation"
  ],
  "h2": [
    "Product Overview‚Äã",
    "Problem Statement‚Äã",
    "Target Users‚Äã",
    "Product Goals‚Äã",
    "Key Features and Requirements‚Äã",
    "User Stories‚Äã",
    "Technical Requirements‚Äã",
    "Architecture Diagrams‚Äã",
    "Demo Video‚Äã",
    "Success Metrics‚Äã",
    "Implementation Considerations‚Äã",
    "Risks and Mitigations‚Äã",
    "Conclusion‚Äã"
  ],
  "h3": [
    "1. Multi-Agent Reasoning System‚Äã",
    "2. Advanced Insights Extraction‚Äã",
    "3. MLR Guardrails for Compliance‚Äã",
    "4. Dynamic Content Adjustment‚Äã",
    "5. Rich Authoring Experience‚Äã",
    "Integration Requirements‚Äã",
    "Security and Compliance‚Äã",
    "Performance Requirements‚Äã",
    "High-Level Architecture‚Äã",
    "C2 Level Architecture‚Äã",
    "AI Ecosystem Integration‚Äã"
  ],
  "text_content": "Press Release Drafter (PRD) | Tech HQ\nSkip to main content\nTech HQ\nInnovate\nPlan\nSolution\nAccess\nLearn\nContribute\nUpdates\nLillyFlow\nüß© Solution Overview\nü§ñ AI & Intelligent Agents\nEcosystem\nPatterns\nPositioning\nExamples\nEnterprise\nPress Release Drafter (PRD)\nPress Release Miner (PRM)\nProduct Exemplars\nAMIGO\nChatNow\nChat in a box\nClinical Programming Assistant\nHR Talent Acquisition Agents\nLillyNow\nPrescriberPoint Kisunla AI Pilot\nPromo Maker\nRevenue Defender\nScientific E-Author\nCoding Tools\nStandards\nAI Submission Guide Template\nüóÑÔ∏è AI & Intelligent Agents BLT\nü§ñ Agentic AI\nüß≠ Conversational AI\nüß≠ Knowledge Bases\nüß≠ Multimodal AI\nüß≠ Translation Services\nüè¢ Business Enablement\n‚òÅÔ∏è Cloud & Infrastructure\nüîê Cybersecurity\nüìä Data & Analytics\nüõ†Ô∏è Engineering Enablement\nüõ∞Ô∏è Observability & Reliability\nüöÄ Team Productivity\nüé® User Experience & Design\nü§ñ AI & Intelligent Agents\nExamples\nEnterprise\nPress Release Drafter (PRD)\nOn this page\nPress Release Drafter (PRD)\nDocument Information\nLast Updated:\nJuly 25, 2025\nOwner:\nBrian Lewis\nPoint of Contact:\nAli Kharazmi\nContributors and Reviewers:\nArchit Kaila, Haitham Maya, Malika Mahoui\nAn Agentic AI System for Press Release Generation\nProduct Overview\n‚Äã\nThe Press Release Drafter (PRD) is an agentic AI product designed for Lilly's corporate communications team to automate\nthe generation of preliminary press releases for clinical trial results. This advanced system leverages multi-agent\nreasoning and natural language processing to create accurate, compliant, and professionally styled press releases that\nalign with Lilly's tone and communication standards.\nProblem Statement\n‚Äã\nCreating press releases for clinical trial results is a time-consuming process that requires:\nExtracting and synthesizing complex clinical data from various sources\nEnsuring medical and regulatory compliance\nMaintaining consistent messaging and brand voice\nCoordinating input from multiple stakeholders\nMeeting tight deadlines for market-sensitive information\nThis process currently demands significant time from skilled communications professionals, medical reviewers, and\nregulatory experts, often leading to bottlenecks in the release pipeline.\nTarget Users\n‚Äã\nCorporate Communications team members\nMedical Affairs professionals\nRegulatory Affairs specialists\nClinical Trial teams\nPublic Relations managers\nProduct Goals\n‚Äã\nReduce the time required to create initial press release drafts by 70%\nEnsure 100% compliance with regulatory requirements and Lilly's communication guidelines\nImprove consistency in messaging across all clinical trial press releases\nEnable communications team to focus on strategic messaging rather than initial drafting\nAccelerate the review cycle by providing higher quality first drafts\nKey Features and Requirements\n‚Äã\n1. Multi-Agent Reasoning System\n‚Äã\nSpecialized agents for data extraction, medical accuracy, regulatory compliance, and content generation\n(\nSupervisor-Worker Agent Pattern\n)\nCollaborative reasoning between agents to resolve conflicts and ensure coherence\n(\nPeer Network Collaboration Pattern\n)\nTransparent decision-making process with justifications for content choices\n2. Advanced Insights Extraction\n‚Äã\nSupport for multiple data source formats:\nText documents (TXT, PDF)\nPresentations (PPTX)\nSpreadsheets (XLSX)\nImages and charts\nWord documents (DOCX)\nAutomated extraction of key clinical trial data points\n(\nReAct Pattern\n):\nPrimary and secondary endpoints\nSafety profiles\nStatistical significance\nPatient demographics\nStudy design details\n3. MLR Guardrails for Compliance\n‚Äã\nBuilt-in Medical, Legal, and Regulatory (MLR) checks\n(\nSelf Critique Pattern\n)\nAutomatic flagging of potential compliance issues\nCitation and reference management\nVerification of claims against source data\nAdverse event reporting compliance\n4. Dynamic Content Adjustment\n‚Äã\nConfigurable tone settings (formal, conversational, technical)\nAdjustable draft length (brief announcement, detailed release, comprehensive background)\nAudience-specific language calibration\nCustomizable emphasis on different aspects of trial results\n5. Rich Authoring Experience\n‚Äã\nInteractive editing interface\nReal-time suggestions and alternatives\nCollaborative review capabilities\nVersion control and change tracking\nComment and feedback integration\nUser Stories\n‚Äã\nCommunications Manager\n\"As a communications manager, I want to quickly generate a first draft press release from clinical trial results so\nthat I can focus on refining messaging strategy rather than creating content from scratch.\"\nMedical Reviewer\n\"As a medical reviewer, I want the AI to accurately represent clinical data and flag potential medical claims that\nrequire additional verification so that I can ensure scientific accuracy.\"\nRegulatory Specialist\n\"As a regulatory specialist, I want the system to automatically check content against current regulatory guidelines\nso that compliance issues are identified early in the drafting process.\"\nPR Director\n\"As a PR director, I want to be able to adjust the tone and length of press releases based on the significance of\nthe results so that our communications are appropriately calibrated to the news.\"\nTechnical Requirements\n‚Äã\nIntegration Requirements\n‚Äã\nSecure connection to clinical trial databases\nIntegration with document management systems\nAPI access to regulatory guidelines database\nConnection to Lilly's brand voice guidelines\nSecurity and Compliance\n‚Äã\nEnd-to-end encryption for all data\nRole-based access controls\nAudit trail for all content generation and edits\nCompliance with data privacy regulations\nSecure handling of pre-public material information\nPerformance Requirements\n‚Äã\nInitial draft generation in under 5 minutes\nSupport for concurrent users across global teams\n99.9% uptime during business hours\nArchitecture Diagrams\n‚Äã\nHigh-Level Architecture\n‚Äã\nThe following diagram illustrates the high-level architecture of the Press Release Drafter (PRD), showing the agents and\ntools involved in the process:\nC2 Level Architecture\n‚Äã\nThe following diagram provides a more detailed C2 (Component and Connector) level view of the system architecture:\nDemo Video\n‚Äã\nA demonstration video of the Press Release Drafter (PRD) in action is available at the following link:\nPress Release Drafter Demo Video\nThis video showcases the key features and workflow of the system, demonstrating how it processes clinical trial data and\ngenerates compliant press releases.\nSuccess Metrics\n‚Äã\nEfficiency Metrics\nTime saved in draft creation process\nReduction in review cycles\nDecrease in time-to-publish\nQuality Metrics\nAccuracy of extracted clinical data\nCompliance success rate\nConsistency with brand voice\nUser satisfaction ratings\nAdoption Metrics\nNumber of active users\nFrequency of use\nFeature utilization rates\nUser retention\nImplementation Considerations\n‚Äã\nAI Ecosystem Integration\n‚Äã\nLeverage Lilly's existing AI ecosystem components:\nGenAI Cortex for core language generation\nAgentic AI framework for multi-agent orchestration\nStructured and Unstructured Knowledgebases for information retrieval\nMLR guardrails from the Responsible AI Layer\nRisks and Mitigations\n‚Äã\nRisk\nImpact\nLikelihood\nMitigation\nInaccurate data extraction\nHigh\nMedium\nImplement confidence scoring and human verification for critical data points\nRegulatory non-compliance\nHigh\nLow\nRegular updates to compliance rules and mandatory human review\nUser resistance\nMedium\nMedium\nPhased rollout with extensive training and clear demonstration of value\nSystem performance issues\nMedium\nLow\nRobust testing and scalable infrastructure design\nData security breach\nHigh\nLow\nEnd-to-end encryption and strict access controls\nConclusion\n‚Äã\nThe Press Release Drafter (PRD) represents a significant advancement in how Lilly approaches corporate communications\nfor clinical trial results. By automating the initial drafting process while ensuring compliance and quality, this tool\nwill enable the communications team to focus on strategic messaging and stakeholder engagement, ultimately improving the\nefficiency and effectiveness of Lilly's external communications.\nWas this helpful?\nEdit this page\nPrevious\nExamples\nNext\nPress Release Miner (PRM)\nProduct Overview\nProblem Statement\nTarget Users\nProduct Goals\nKey Features and Requirements\n1. Multi-Agent Reasoning System\n2. Advanced Insights Extraction\n3. MLR Guardrails for Compliance\n4. Dynamic Content Adjustment\n5. Rich Authoring Experience\nUser Stories\nTechnical Requirements\nIntegration Requirements\nSecurity and Compliance\nPerformance Requirements\nArchitecture Diagrams\nHigh-Level Architecture\nC2 Level Architecture\nDemo Video\nSuccess Metrics\nImplementation Considerations\nAI Ecosystem Integration\nRisks and Mitigations\nConclusion\nCommunity\nEBA Viva Engage\nEBA SharePoint\nQuestions?\nReach us on Viva Engage!\nCopyright ¬© 2026 Eli Lilly and Company",
  "links_found": 12,
  "depth": 3,
  "crawled_at": "2026-02-25T10:08:22.108487"
}